Last reviewed · How we verify

NCT05214937

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Recruiting now NA Last updated 4 December 2024
What this trial tests

NA trial testing Intervention in Sedentary Behavior in 120 participants. Currently enrolling.

Timeline
15 February 2022
Primary endpoint
1 December 2025
1 December 2026

Quick facts

Lead sponsorUniversity of Toronto
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment120
Start date15 February 2022
Primary completion1 December 2025
Estimated completion1 December 2026
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Toronto

Who can join

18 and older, male only, with Sedentary Behavior or Cancer of Prostate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial (RCT) will aim to examine the effect of a 12-week behavioural intervention on changing the sedentary behaviours (SB) of prostate cancer survivors (PCS) compared to a control group (FitBit-only group). PCS in the intervention group will receive a FitBit and 6 behavioural support sessions with a movement specialist guided by behavioural theory (i.e., the Multi-Process Action Control \[M-PAC\]). The FitBit-only group will only receive a FitBit and access to public health resources on physical activity (PA). The primary purpose of this study is to determine the efficacy of the intervention on changing SB of PCS immediately following the 12-week intervention and 6-months later. It is hypothesized that that the intervention will decrease their SB compared to the FitBit-only control condition at both timepoints. This trial will also examine the effect of the intervention on changing PA, motivational outcomes from the M-PAC framework, sleep quality, social support, physical function, quality of life, fatigue, disability and mental health compared to the active control condition.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A distance-based, randomized controlled trial for reducing sedentary behavior among prostate cancer survivors: a study protocol.
    Trinh L, Sabiston CM, Alibhai SMH, Jones JM, et al · · 2022 · cited 2× · PMID 35484523 · DOI 10.1186/s12889-022-13218-5

Verify or expand the search:

Other trials of Intervention

Trials testing the same drug.

Other recruiting trials for Sedentary Behavior

Currently open trials in the same condition.

Other University of Toronto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05214937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing